secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001493152-25-010921
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals implements 1-for-50 reverse stock split effective March 17, 2025
--------------------------------------------------------------------------------

- Every 50 pre-split shares reclassified into 1 share; par value unchanged at $0.0001.
- Authorized shares of common and preferred stock remain unchanged.
- No fractional shares issued; stockholders receive cash in lieu of fractions.
- Outstanding options and warrants adjusted proportionately; exercise prices increased.
- New CUSIP number is 426897401; stock continues trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315225010921/0001493152-25-010921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315225010921/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer